Change in urinary myoinositol/citrate ratio associates with progressive loss of renal function in ADPRD patients
Introduction: In autosomal dominant polycystic kidney disease (ADPKD) patients, predicting renal disease progression is important to make a prognosis and to support the clinical decision whether to initiate renoprotective therapy. Conventional markers all have their limitations. Metabolic profiling...
| Published in: | American journal of nephrology Vol. 53, № 6. P. 470-480 |
|---|---|
| Other Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | http://vital.lib.tsu.ru/vital/access/manager/Repository/koha:001000863 |